• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORETION LIXELLE BETA2-MICROGLOBULIN APHERESIS COLUMN; BETA 2-MICROGLOBULIN APHERESIS COLUMN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORETION LIXELLE BETA2-MICROGLOBULIN APHERESIS COLUMN; BETA 2-MICROGLOBULIN APHERESIS COLUMN Back to Search Results
Model Number S-15
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problems Chest Pain (1776); Low Oxygen Saturation (2477); Presyncope (4410)
Event Date 03/27/2023
Event Type  Injury  
Manufacturer Narrative
Our view: the item had already been disposed of, so it was not possible to confirm its condition.The lot number of the product was not reported and was not included in the disclosed information, so the manufacturing records, etc.Could not be confirmed.As there were no similar reports in the recent past, it was determined that there was no possibility that the cause of the event was a defect in the product.
 
Event Description
A patient (63 years old, male) who received the first treatment with this product on (b)(6) 2023 became in the state of "chest pain, unconsciousness, and decreased spo2 (93%)" about 1 hour after the start.Details of action taken: treatment was urgently stopped (finished), and steroid administration was implemented.Outcome: two days later, on (b)(6)2023, the patient's symptoms resolved.Further treatment with lixelle for this patient has been discontinued.In addition, we tried to obtain additional information multiple times, but we did not receive a response from the facility, so the details of the problem other than the above are unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIXELLE BETA2-MICROGLOBULIN APHERESIS COLUMN
Type of Device
BETA 2-MICROGLOBULIN APHERESIS COLUMN
Manufacturer (Section D)
KANEKA CORPORETION
nakanoshima
kita-ku 2-3-18
osaka-shi, osaka 530-8 5288
JA  530-85288
Manufacturer (Section G)
KANEKA CORPORATION OSAKA PLANT
5-1-1
torikai-nishi
settu-shi, osaka 566-0 072
JA   566-0072
Manufacturer Contact
joji sengoku
1-12-32
akasaka
minato-ku, tokyo 107-6-028
JA   107-6028
MDR Report Key16821796
MDR Text Key314074070
Report Number3002808904-2023-00003
Device Sequence Number1
Product Code PDI
UDI-Device Identifier14993478020218
UDI-Public14993478020218
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberS-15
Device Catalogue NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/31/2023
Initial Date FDA Received04/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age63 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-